Demand for biosimilars is expected to increase significantly in the coming years, particularly in the United States. Developing new biosimilar candidates is a challenging endeavor that requires partnerships with outsourcing partners that have deep protein science, analytics, and process engineering expertise. Avid Bioservices has successfully supported biosimilar development for nearly a decade and is further expanding its capacity to provide manufacturing services from the bench through larger-scale commercialization. Anticipating Strong Growth in Demand for Biosimilars The value of the global…